Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus

Timothy Gilbey, Josephine Ho, Louise A Cooley, Aleksandra Petrovic Fabijan and Jonathan R Iredell
Med J Aust 2019; 211 (3): . || doi: 10.5694/mja2.50274
Published online: 5 August 2019

To the Editor: Infective endocarditis with Staphylococcus aureus is associated with a high mortality despite optimal antibiotic therapy.1 The synergy between bacteriophages and antibiotics has been shown in vitro and in animal studies,2 and bacteriophages have demonstrated their value in severe bacterial infections.3 AB‐SA01 (AmpliPhi Biosciences) is a bacterial DNA‐free and protein‐free highly purified preparation of three obligately lytic Myoviridae, each at 109 plaque‐forming units per dose.4 This preparation has been recently used successfully for staphylococcal sinusitis by local irrigation.5 A protocol was established for bacteriophage therapy as an adjunct to standard care of severe staphylococcal infections under the auspices of the Therapeutic Goods Administration Special Access Scheme. Here, we report the first intravenous use of AB‐SA01 in a case of severe staphylococcal sepsis with prosthetic valve endocarditis.

  • Timothy Gilbey1
  • Josephine Ho1,2
  • Louise A Cooley3
  • Aleksandra Petrovic Fabijan2
  • Jonathan R Iredell1,2,4

  • 1 Westmead Hospital, Sydney, NSW.
  • 2 Westmead Institute for Medical Research, Sydney, NSW.
  • 3 Royal Hobart Hospital, Hobart, TAS.
  • 4 University of Sydney, Sydney, NSW.


This manuscript was prepared in collaboration with the Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi BioSciences. We thank Patricia Fa for pharmacy support, Ruby Lin (WBTT project manager and scientific lead) for project support, and Belinda Dillon‐Roychoudhry for technical assistance.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.